UGLEVODLAR ALMASHINUVI BUZILISHLARINING XAVF OMILLARINI UCHRASHISH TEZLIGINI BAHOLASH
Abstrakt
Tadqiqot maqsadi: Tadqiqotning maqsadi Andijon viloyatining qishloq aholisi orasida prediabet va diabet xavf omillarining uchrashish tezligini baholashdir. Tadqiqot materiallari va metodlari: Tadqiqotda Andijon viloyatining Marhamat tumanida istiqomat qiluvchi 1800 nafar ishtirokchi ishtirok etdi, bu qishloq aholisi orasida 10% ni tashkil etadigan tasodifiy namunadir. Ishtirokchilarga antropometrik o'lchovlar (tana massasi indeksini hisoblash, bel-qovurg'a nisbati), "DiaXatar" anketasi orqali prediabet va diabet xavf omillarini baholash, laboratoriya va biokimyoviy tekshiruvlar uchun qon namunalarini olish (qon va siydik tahlillari, xolesterin, triglitseridlar, qand, glyukozalangan gemoglobin, insulinni aniqlash, HOMA-IR hisoblash) amalga oshirildi. Natijalar: Olingan natijalar prediabet va 2-tip diabet uchun eng muhim xavf omillarini aniqladi: yosh — prediabet uchun 45-54 yosh, 2-tip diabet uchun 54-65 yosh; ayol jins (prediabet va 2-tip diabet uchun); DiaXatar balli — "≥6-10 ball" (glykemik buzilishlar uchun past xavf), "≥16-20 ball" (glykemik buzilishlar uchun o'rtacha xavf), "≥21 ball" (glykemik buzilishlar rivojlanishining yuqori xavfi); BMI (erkaklar uchun prediabet uchun ≥29.4 kg/m², 2-tip diabet uchun ≥30.8 kg/m²; ayollar uchun prediabet va 2-tip diabet uchun mos ravishda ≥31.5 kg/m²). Xulosa: Andijon viloyatining qishloq aholisi orasida prediabetning regional, jinsiy, yosh va epidemiyologik xususiyatlari aniqlangan.
Nashr sanasi
Mualliflar haqida
Adabiyotlar ro'yxati
Demidova T.Yu., Kishkovich Yu.S. Prediabetes: current state of the problem and possibilities of correction // RMJ. Medical Review. - 2019. - Vol.3, No.10 (II). - P.60-67.
Nedogoda S.V., Barykina I.N., Salasyuk A.S. et al. Prediabetes: main causes, symptoms, prevention and treatment // Medicinal Bulletin. - 2018. - Vol.70, No.2. - P.3-13.
ADA. Classification and Diagnosis of Diabetes // Diabetes Care. - 2017. - N40. - P.11-24.
Demidova T.Yu., Plakhotnaya V.M. Prediabetes. New paradigm of early prevention of cardiovascular diseases // Medical Council. - 2021. - No. 14. - P. 124-132.
Cheung B.M., Li C. Diabetes and hypertension: is there a common metabolic pathway? // Curr. Atheroscler. Rep. – 2012. – Vol.14, N2. – С.160–166.
Glechner A., Keuchel L., Affengruber L. et al. Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis // Prim. Care Diabetes. – 2018. - N12. – P.393–408.
Tabák A.G., Herder C., Rathmann W. et al. Prediabetes: a high-risk state for diabetes development // Lancet. – 2012. - N379. – P.2279–90.
Geva M., Shlomai G., Berkovich A. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension // Cardiovasc Diabetol. – 2019. – Vol.18, N1. – P.53.
Ridderstrale W., Saluveer O., Carlstrom M., Jern S., Hrafnkelsdottir T.J. The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering // J. Thromb. Thrombolysis. – 2011. - N32. – P.399–404.
Makisheva R.T. Measures to reduce cardiovascular risk in diabetes mellitus and prediabetes // Bulletin of new medical technologies. Electronic ed. - 2017. - No. 1. - P.102-109.
Fox C.S., Golden S.H., Anderson C. et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence // Diabetes Care. – 2015. - N38. – P.1777–1803.
Hayward R.A., Reaven P.D., Wiitala W.L. et al. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes // N. Engl. J. Med. – 2015. - N372. – P.2197–2206.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.